{
    "eid": "2-s2.0-85163218603",
    "title": "Systemic lupus erythematosus associated with development of macrophage activation syndrome and disseminated aspergillosis Lupus \u00e9ryth\u00e9mateux diss\u00e9min\u00e9 associ\u00e9 au d\u00e9veloppement du syndrome d\u2019activation macrophagique et \u00e0 une aspergillose diss\u00e9min\u00e9e",
    "cover-date": "2023-07-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Anesthesiology and Pain Medicine",
            "@code": "2703",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "fungal infection",
        "macrophage activation syndrome",
        "systemic lupus erythematosus",
        "tracheobronchitis"
    ],
    "authors": [
        "Vorakamol Phoophiboon",
        "Paula Brown",
        "Karen E.A. Burns"
    ],
    "citedby-count": 0,
    "ref-count": 28,
    "ref-list": [
        "Recurrent macrophage activation syndrome as the primary manifestation in systemic lupus erythematosus and the benefit of serial ferritin measurements: a case-based review",
        "HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis",
        "Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome",
        "Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome",
        "2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative",
        "Macrophage activation syndrome: early diagnosis is key",
        "Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis",
        "Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients",
        "Exploring macrophage activation syndrome secondary to systemic lupus erythematosus in adults: a systematic review of the literature",
        "Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes",
        "2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus",
        "2019 update of the EULAR recommendations for the management of systemic lupus erythematosus",
        "Macrophage activation syndrome in systemic lupus erythematosus: a multicenter, case-control study in China",
        "Case report: macrophage activation syndrome and widespread neuroimaging abnormality in childhood-onset systemic lupus erythematosus",
        "Serology of lupus erythematosus: correlation between immunopathological features and clinical aspects",
        "Pseudomembranous tracheitis caused by Aspergillus fumigatus in the setting of high grade T-cell lymphoma",
        "Fungal tracheobronchitis. Report of 9 cases and review of the literature",
        "Invasive aspergillus tracheobronchitis emerging as a highly lethal complication of severe influenza",
        "Invasive pulmonary aspergillosis in immunocompetent patients hospitalised with influenza A-related pneumonia: a multicenter retrospective study",
        "Airway obstruction and acute respiratory failure due to Aspergillus tracheobronchitis",
        "Aspergillus tracheobronchitis in a mild immunocompromised host",
        "Efficacy of voriconazole against aspergillus fumigatus infection depends on host immune function",
        "Executive Summary: practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America",
        "Voriconazole versus Amphotericin B for primary therapy of invasive aspergillosis",
        "Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology",
        "Plasma protein binding of amphotericin B and pharmacokinetics of bound versus unbound amphotericin B after administration of intravenous liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate",
        "Pharmacokinetics of commonly used antimicrobials in critically ill adults during extracorporeal membrane oxygenation: a systematic review"
    ],
    "affiliation": [
        {
            "affiliation-city": "Toronto",
            "@id": "60270056",
            "affilname": "Unity Health Toronto",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60270056",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Toronto",
            "@id": "60016849",
            "affilname": "University of Toronto",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016849",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Toronto",
            "@id": "60014468",
            "affilname": "University Health Network University of Toronto",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60014468",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}